Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck
Clinical trial NCT03132038 · COMPLETED
Trial details
- NCT number
- NCT03132038
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-24
- Primary completion
- 2019-01-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.